Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
for
Head Lice
Location: Enid OK
Sponsor: Oystershell NV
Sex: All
Age: 0+
Code: NCT07191457
Recruiting
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
for
Ulcerative Colitis, Crohn's Disease
Location: Oklahoma City OK
Sponsor: Takeda
Sex: All
Age: 2 - 17
Code: NCT06405087
Phase3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Hawthorne NY, The Bronx NY, Ocean City NJ, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Portland ME, South Portland ME, Boston MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
for
Endometrial Cancer
Location: St. John's, New Haven CT, Mineola NY, New York NY,
Sponsor: BioNTech SE
Sex: Female
Age: 18+
Code: NCT06340568
Phase3, Recruiting
Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
Location: Boston MA, Allentown PA, Bethesda MD, Oklahoma City OK
Sponsor: Skylark Bio Inc.
Sex: All
Age: 0 - 7
Code: NCT07627971
Phase1, Phase2, Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for
Hypercholesterolemia
Location: Wilmington NC, Charlottesville VA, Durham NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07477704
Phase2, Recruiting
NORM-HF Pivotal Study
for
Heart Failure, NYHA Class III Heart Failure,
Location: Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
Sex: All
Age: 18+
Code: NCT07574593
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Worcester MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
for
Hypertension (HTN)
Location: Berlin NJ, Ft. Washington MD, Wellington FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07543120
Phase2, Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Lutherville MD,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
for
Liver Fibrosis, Hepatic Cirrhosis
Location: Morehead City NC, Raleigh NC, Jupiter FL, Miami FL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07610837
Phase2, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Mooresville NC, Crystal River FL, Knoxville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Boston MA, The Bronx NY, Wilkes-Barre PA, Syracuse NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase2, Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
for
Acute Gouty Arthritis, Gout Flare, Gout Flares,
Location: Lutherville MD, Naperville IL, Gulfport MS,
Sponsor: Atom Therapeutics Co., Ltd
Sex: All
Age: 18 - 70
Code: NCT07145229
Phase2, Recruiting
Empowering Cessation ACS South Region
for
Smoking Cessation
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 18 - 70+
Code: NCT06820034
Phase2, Phase3, Recruiting
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: New York NY, Philadelphia PA, Sweetwater FL, Sanford FL,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 70+
Code: NCT07049575
Phase1, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma